Workflow
互联医疗
icon
Search documents
依米康涨2.01%,成交额1.60亿元,主力资金净流入269.07万元
Xin Lang Cai Jing· 2025-09-05 03:16
Core Viewpoint - The company, Yimikang Technology Group Co., Ltd., has shown significant growth in revenue and net profit in the first half of 2025, indicating strong operational performance and market demand for its services in the digital infrastructure sector [2]. Group 1: Stock Performance - On September 5, Yimikang's stock price increased by 2.01%, reaching 16.24 CNY per share, with a trading volume of 1.60 billion CNY and a turnover rate of 2.68%, resulting in a total market capitalization of 71.54 billion CNY [1]. - Year-to-date, Yimikang's stock price has risen by 27.07%, but it has experienced a decline of 11.11% over the last five trading days and a decrease of 4.02% over the last 20 days [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on February 14, where it recorded a net purchase of 51.66 million CNY [1]. Group 2: Company Overview - Yimikang, established on September 12, 2002, and listed on August 3, 2011, is based in Chengdu, Sichuan Province, and specializes in providing green solutions for the entire lifecycle of digital infrastructure [2]. - The company's main business revenue is derived entirely from ICT products, and it operates across four key segments: critical equipment, smart engineering, IoT software, and intelligent services [2]. - As of June 30, the number of shareholders decreased by 8.79% to 59,700, while the average circulating shares per person increased by 9.59% to 6,249 shares [2]. Group 3: Financial Performance - For the first half of 2025, Yimikang reported a revenue of 737 million CNY, representing a year-on-year growth of 54.82%, and a net profit attributable to shareholders of 14.92 million CNY, which is a 124.13% increase compared to the previous year [2].
中电港涨2.00%,成交额1.42亿元,主力资金净流入1037.36万元
Xin Lang Cai Jing· 2025-09-05 03:14
Core Viewpoint - The stock of China Electric Port has shown fluctuations in trading performance, with a recent increase of 2.00% and a total market capitalization of 15.479 billion yuan as of September 5 [1] Group 1: Stock Performance - As of September 5, the stock price of China Electric Port is 20.37 yuan per share, with a trading volume of 142 million yuan and a turnover rate of 1.61% [1] - Year-to-date, the stock price has increased by 0.85%, but it has decreased by 9.39% over the last five trading days [1] - The stock has appeared on the "Dragon and Tiger List" four times this year, with the most recent appearance on July 21, where it recorded a net buy of -86.0912 million yuan [1] Group 2: Company Overview - China Electric Port, established on September 28, 2014, is located in Shenzhen, Guangdong Province, and was listed on April 10, 2023 [2] - The company primarily engages in electronic component distribution, accounting for 99.89% of its revenue, with other services making up the remaining 0.11% [2] - The company operates in the electronic industry, specifically in the sub-sectors of other electronics [2] Group 3: Financial Performance - For the first half of 2025, China Electric Port reported a revenue of 33.526 billion yuan, representing a year-on-year growth of 35.64%, and a net profit attributable to shareholders of 181 million yuan, up 64.98% [2] - Since its A-share listing, the company has distributed a total of 258 million yuan in dividends [3] Group 4: Shareholder Information - As of June 30, 2025, the number of shareholders for China Electric Port is 76,700, a decrease of 10.72% from the previous period [2] - The top ten circulating shareholders include various ETFs, with notable increases in holdings from Southern CSI 1000 ETF and others [3]
海思科跌2.04%,成交额5276.39万元,主力资金净流入194.01万元
Xin Lang Cai Jing· 2025-09-05 03:14
Company Overview - Haisco Pharmaceutical Group Co., Ltd. is located in Zedang Town, Shannan City, Tibet, and was established on August 26, 2005. The company was listed on January 17, 2012. Its main business involves the research, development, production, and sales of chemical pharmaceuticals. The revenue composition is 99.14% from the pharmaceutical industry and 0.86% from other sources [1]. Stock Performance - As of September 5, Haisco's stock price decreased by 2.04%, trading at 56.10 CNY per share, with a total market capitalization of 62.827 billion CNY. The stock has increased by 70.10% year-to-date, with a 1.15% increase over the last five trading days, a 5.65% decrease over the last 20 days, and a 20.78% increase over the last 60 days [1]. Financial Performance - For the first half of 2025, Haisco reported a revenue of 2.001 billion CNY, representing a year-on-year growth of 18.63%. However, the net profit attributable to shareholders decreased by 21.79% to 129 million CNY [2]. Shareholder Information - As of June 30, 2025, Haisco had 11,400 shareholders, an increase of 25.93% from the previous period. The average number of tradable shares per shareholder decreased by 28.64% to 42,147 shares [2]. Dividend Distribution - Haisco has distributed a total of 3.673 billion CNY in dividends since its A-share listing, with 687 million CNY distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, among the top ten circulating shareholders, several funds increased their holdings, including China Europe Medical Health Mixed A, which holds 21.2763 million shares, an increase of 5.3574 million shares. Other funds also saw increases, while one fund reduced its holdings [3].
万马科技涨2.22%,成交额1.20亿元,主力资金净流入15.65万元
Xin Lang Cai Jing· 2025-09-03 03:43
Company Overview - Wanma Technology Co., Ltd. is located in Qingyun Village, Taihu Source Town, Lin'an District, Hangzhou, Zhejiang Province, established on January 28, 1997, and listed on August 31, 2017 [2] - The company's main business includes the research, production, system integration, and sales of communication and medical information technology equipment, as well as the integration and maintenance of data centers [2] - The revenue composition of Wanma Technology is as follows: 46.44% from vehicle networking, 30.39% from cabinet and chassis products, 11.64% from industrial control products, 6.64% from other sources, and 4.89% from medical information technology products [2] Financial Performance - For the first half of 2025, Wanma Technology achieved operating revenue of 339 million yuan, a year-on-year increase of 50.91%, and a net profit attributable to shareholders of 16.46 million yuan, a year-on-year increase of 3.06% [2] - Since its A-share listing, Wanma Technology has distributed a total of 35.24 million yuan in dividends, with 30.82 million yuan distributed over the past three years [3] Stock Performance - On September 3, Wanma Technology's stock price increased by 2.22%, reaching 45.22 yuan per share, with a trading volume of 120 million yuan and a turnover rate of 2.29%, resulting in a total market capitalization of 6.059 billion yuan [1] - Year-to-date, Wanma Technology's stock price has risen by 31.22%, with a decline of 3.97% over the last five trading days and a decline of 3.44% over the last 20 days, while it has increased by 21.14% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on June 24, where it recorded a net purchase of 104 million yuan [1] Capital Flow - In terms of capital flow, the net inflow of main funds was 156,500 yuan, with large orders accounting for 16.62% of both buy and sell transactions [1]
万东医疗跌2.00%,成交额4549.14万元,主力资金净流出244.79万元
Xin Lang Cai Jing· 2025-09-03 02:42
Core Viewpoint - WanDong Medical's stock price has experienced fluctuations, with a year-to-date increase of 14.56% but a recent decline in the last five trading days by 3.22% [1] Company Overview - WanDong Medical, established on May 12, 1997, and listed on May 19, 1997, is located in Chaoyang District, Beijing. The company specializes in the research, manufacturing, sales of imaging medical devices, and imaging diagnostic services [1] - The main revenue composition includes 88.18% from medical device sales, 6.32% from other supplementary services, and 5.51% from labor and services [1] Financial Performance - For the first half of 2025, WanDong Medical reported a revenue of 843 million yuan, representing a year-on-year growth of 20.46%. However, the net profit attributable to shareholders decreased by 39.46% to 51.3 million yuan [2] - Cumulative cash dividends since the A-share listing amount to 769 million yuan, with 267 million yuan distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 11.69% to 26,800, while the average circulating shares per person increased by 13.24% to 26,201 shares [2] - The top ten circulating shareholders include notable entities such as Huabao Zhongzheng Medical ETF and Hong Kong Central Clearing Limited, with changes in their holdings compared to the previous period [3]
万马科技跌2.04%,成交额1.83亿元,主力资金净流出3629.02万元
Xin Lang Cai Jing· 2025-09-01 06:23
Company Overview - Wanma Technology Co., Ltd. is located in Qingyun Village, Taihu Source Town, Lin'an District, Hangzhou, Zhejiang Province, and was established on January 28, 1997. The company was listed on August 31, 2017 [2] - The main business involves the research, development, production, system integration, and sales of communication and medical information technology equipment, as well as the integration and maintenance of data centers [2] - The revenue composition includes: 46.44% from vehicle networking, 30.39% from cabinet and chassis products, 11.64% from industrial control products, 6.64% from other products, and 4.89% from medical information technology products [2] Financial Performance - For the first half of 2025, Wanma Technology achieved operating revenue of 339 million yuan, a year-on-year increase of 50.91%, and a net profit attributable to the parent company of 16.46 million yuan, a year-on-year increase of 3.06% [2] - The company has cumulatively distributed cash dividends of 35.24 million yuan since its A-share listing, with 30.82 million yuan distributed over the past three years [3] Stock Performance - As of September 1, Wanma Technology's stock price was 46.53 yuan per share, with a market capitalization of 6.235 billion yuan. The stock has increased by 35.03% year-to-date, but has decreased by 4.44% over the past five trading days [1] - The stock has seen a net outflow of 36.29 million yuan in principal funds, with significant selling pressure from large orders [1] - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 104 million yuan on June 24 [1]
久远银海跌2.02%,成交额2.31亿元,主力资金净流出2056.80万元
Xin Lang Cai Jing· 2025-08-29 07:13
Core Viewpoint - JiuYuan YinHai's stock price has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 16.23%, indicating volatility in market performance [1] Financial Performance - For the first half of 2025, JiuYuan YinHai reported revenue of 439 million yuan, representing a year-on-year growth of 11.33% [2] - The net profit attributable to shareholders for the same period was approximately 29.95 million yuan, showing a significant increase of 166.63% year-on-year [2] Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 5.68% to 54,400, while the average number of circulating shares per person increased by 6.02% to 7,433 shares [2] - The company has distributed a total of 472 million yuan in dividends since its A-share listing, with 151 million yuan distributed over the past three years [3] Major Shareholders - As of June 30, 2025, Hong Kong Central Clearing Limited is the third-largest circulating shareholder, increasing its holdings by 910,200 shares to 4.6232 million shares [3] - Southern CSI 1000 ETF is the fifth-largest circulating shareholder, increasing its holdings by 489,700 shares to 2.6339 million shares [3] - E-Fonda New Normal Mixed Fund is a new entrant among the top ten circulating shareholders, holding 2.2 million shares [3]
数字认证跌2.03%,成交额1.49亿元,主力资金净流出1731.83万元
Xin Lang Cai Jing· 2025-08-29 04:08
Core Viewpoint - Digital Authentication's stock price has experienced fluctuations, with a year-to-date increase of 18.19% but a recent decline of 9.51% over the past five trading days [1] Financial Performance - For the first half of 2025, Digital Authentication reported revenue of 325 million yuan, a year-on-year decrease of 21.13%, and a net profit attributable to shareholders of -90.35 million yuan, a decline of 208.89% [2] - The company has distributed a total of 144 million yuan in dividends since its A-share listing, with 17.55 million yuan distributed over the past three years [3] Stock Market Activity - As of August 29, Digital Authentication's stock was trading at 37.10 yuan per share, with a market capitalization of 10.017 billion yuan [1] - The stock has seen significant trading activity, with a net outflow of 17.32 million yuan in principal funds on August 29, and a notable presence on the "Dragon and Tiger List" with a net buy of 84.94 million yuan on July 31 [1] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 22.71% to 28,900, while the average circulating shares per person decreased by 18.51% to 9,085 shares [2] - Notable institutional shareholders include Southern CSI 1000 ETF and Huabao CSI Financial Technology Theme ETF, with the former being a new entrant among the top ten shareholders [3] Business Overview - Digital Authentication, established on February 28, 2001, specializes in electronic certification services, security integration, security consulting, and operation and maintenance services [1] - The company's revenue composition includes electronic certification services (31.24%), network security services (29.16%), network security products (28.36%), and network security integration (11.24%) [1]
乐普医疗跌2.04%,成交额8.46亿元,主力资金净流入662.44万元
Xin Lang Zheng Quan· 2025-08-28 06:22
Group 1 - The core viewpoint of the news is that Lepu Medical's stock has shown significant growth this year, with a year-to-date increase of 66.85% and notable recent trading activity [1][2] - As of August 28, Lepu Medical's stock price was 18.70 yuan per share, with a total market capitalization of 35.167 billion yuan [1] - The company has a diverse revenue structure, with medical devices accounting for 52.72%, pharmaceuticals 33.16%, and medical services and health management 14.11% of total revenue [2] Group 2 - Lepu Medical has distributed a total of 4.657 billion yuan in dividends since its A-share listing, with 1.758 billion yuan distributed in the last three years [3] - As of June 30, 2025, the number of shareholders increased by 6.18% to 100,100, while the average circulating shares per person decreased by 5.82% to 16,152 shares [2][3] - The company has seen changes in institutional holdings, with notable increases and decreases among its top shareholders [3]
久远银海跌2.02%,成交额2.32亿元,主力资金净流出2530.19万元
Xin Lang Cai Jing· 2025-08-28 04:05
Group 1 - The core viewpoint of the news is that Jiuyuan Yinhai's stock has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 16.23% [1] - As of June 30, 2025, Jiuyuan Yinhai reported a revenue of 439 million yuan, representing a year-on-year growth of 11.33%, and a net profit of approximately 29.95 million yuan, which is a significant increase of 166.63% compared to the previous year [2] - The company has distributed a total of 472 million yuan in dividends since its A-share listing, with 151 million yuan distributed in the last three years [3] Group 2 - Jiuyuan Yinhai's main business segments include operation and maintenance services (49.40%), software (34.76%), and system integration (15.60%) [1] - As of June 30, 2025, the number of Jiuyuan Yinhai's shareholders decreased by 5.68% to 54,400, while the average number of circulating shares per person increased by 6.02% to 7,433 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 910,200 shares, and new shareholder E Fund New Normal Mixed Fund, which holds 2.2 million shares [3]